Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.69
-0.04 (-2.03%)
At close: Jun 17, 2025, 3:59 PM
1.68
-0.58%
After-hours: Jun 17, 2025, 07:52 PM EDT
-2.03% (1D)
| Bid | 1.65 |
| Market Cap | 3.82M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.52M |
| EPS (ttm) | -6.6 |
| PE Ratio (ttm) | -0.26 |
| Forward PE | -1.89 |
| Analyst | n/a |
| Ask | 1.76 |
| Volume | 266,068 |
| Avg. Volume (20D) | 1,664,031 |
| Open | 1.72 |
| Previous Close | 1.73 |
| Day's Range | 1.66 - 1.74 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.51 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
1 month ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
8 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
